Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Glial Cells01:04

Glial Cells

92.5K
Overview
92.5K
Neural Regulation01:37

Neural Regulation

42.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

825
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
825

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted α-synuclein mRNA degradation by PMO-based RNA-degrading chimeras.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

In-vivo iron mapping in patients with Parkinson's disease using deep learning-based susceptibility source separation MRI.

NPJ Parkinson's disease·2026
Same author

PARP1 deficiency mitigates amyloid pathology, neurodegeneration, and cognitive decline in a familial Alzheimer's disease model.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Protocols for Assessing the Nuclease Activity of MIF.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Deep-learning saturation transfer magnetic resonance fingerprinting (ST-MRF) in patients with Parkinson's disease.

NeuroImage·2026
Same author

Machine learning model based on plasma proteomics for the identification of Parkinson's disease.

Brain : a journal of neurology·2026

Related Experiment Video

Updated: Dec 13, 2025

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

16.5K

Microglia and astrocyte dysfunction in parkinson's disease.

Tae-In Kam1, Jared T Hinkle2, Ted M Dawson3

  • 1Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Neurobiology of Disease
|August 1, 2020
PubMed
Summary

Glial cell dysfunction, particularly in microglia and astrocytes, is increasingly linked to Parkinson's disease (PD) pathogenesis. Understanding these roles offers potential new therapeutic targets for neurodegeneration.

Keywords:
AstrocyteGliaMicrogliaNeurodegenerationNeurodegenerative diseaseNeuroinflammationParkinson's disease

More Related Videos

Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
09:36

Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis

Published on: June 23, 2022

3.8K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.0K

Related Experiment Videos

Last Updated: Dec 13, 2025

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

16.5K
Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
09:36

Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis

Published on: June 23, 2022

3.8K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.0K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Glial cells (microglia and astrocytes) are vital for brain homeostasis.
  • Glial cell dysfunction is implicated in neurodegenerative diseases like Parkinson's disease (PD).
  • PD-associated genes are expressed in glial cells, highlighting their role in the disease.

Purpose of the Study:

  • To discuss the role of microglia and astrocyte dysfunction in Parkinson's disease.
  • To explore the implications of PD-linked mutations in glial cells for disease pathogenesis.
  • To provide insights into neurodegeneration and potential therapeutic strategies for PD.

Main Methods:

  • Literature review and synthesis of recent studies on glial cells in PD.
  • Analysis of PD-associated gene expression in microglia and astrocytes.
  • Discussion of the functional roles of glial cells in PD pathogenesis.

Main Results:

  • PD-associated genes play crucial roles in microglia and astrocytes.
  • Dysfunction of these glial cells contributes significantly to neurodegeneration in PD.
  • Glial cell involvement is a key aspect of PD pathogenesis.

Conclusions:

  • Glial cell dysfunction is central to Parkinson's disease.
  • Targeting microglia and astrocytes may offer novel therapeutic avenues for PD.
  • Further research into glial cell function is essential for understanding and treating PD.